HIGHBRIDGE CAPITAL MANAGEMENT LLC - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845P908. A total of 4 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HIGHBRIDGE CAPITAL MANAGEMENT LLC ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2022$3,793,000233,1000.09%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 71,700$962,9310.00%
JANE STREET GROUP, LLC 104,000$1,396,7200.00%
SIMPLEX TRADING, LLC 58,400$7840.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders